Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanical and Electrochemical Corrosion Behavior of Porous Ti-10Zr-xNb Alloys Processed via Powder Metallurgy for Biomedical Implants.

ACS biomaterials science & engineering·2026
Same author

A Study of Feasibility for Reusing Thermoplastic Masks - Toward a Green Environment.

Journal of medical physics·2026
Same author

Vascular whispers and anaemia: Unravelling hereditary haemorrhagic telangiectasia.

Medical journal, Armed Forces India·2026
Same author

Chasing clarity in acute pancreatitis: Comparing computed tomography severity index and APACHE-II score in predicting severity in Indian patients.

Medical journal, Armed Forces India·2026
Same author

Exploring novel resistant sources for chilli leaf curl disease in Capsicum annuum L. germplasm for genetic enhancement.

Scientific reports·2026
Same author

Comprehensive phenotyping of 1,807 Indian barnyard millet (<i>Echinochloa frumentacea</i> Link) accessions from Indian national genebank: unlocking diversity for core set development.

Frontiers in plant science·2025

Related Experiment Video

Updated: Jul 13, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Histoid leprosy with ENL reaction.

Suresh K Sharma1, Namita Rath, R K Gautam

  • 1Department of Skin and STD, Dr RML Hospital, New Delhi-110 001, India.

Indian Journal of Dermatology, Venereology and Leprology
|July 28, 2007
PubMed
Summary

Histoid leprosy can manifest with firm nodules that may suppurate during multidrug therapy (MDT). These nodules can exhibit erythema nodosum leprosum (ENL), a rare but significant finding in this leprosy form.

More Related Videos

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

Related Experiment Videos

Last Updated: Jul 13, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Pathology

Background:

  • Histoid leprosy is a rare form of Mycobacterium leprae infection.
  • Cutaneous and subcutaneous nodules are characteristic manifestations.
  • Multidrug therapy (MDT) is the standard treatment.

Purpose of the Study:

  • To report a case of histoid leprosy with unusual erythema nodosum leprosum (ENL) development.
  • To highlight the histopathological features of ENL in this context.

Main Methods:

  • Clinical presentation of a 23-year-old male patient with histoid leprosy.
  • Observation of nodule suppuration during MDT.
  • Histopathological examination of suppurated nodules.

Main Results:

  • The patient presented with firm cutaneous and subcutaneous nodules.
  • Some nodules suppurated following initiation of MDT.
  • Histopathology confirmed erythema nodosum leprosum (ENL) in the suppurated nodules.

Conclusions:

  • Erythema nodosum leprosum (ENL) can occur in histoid leprosy, even after the initiation of MDT.
  • This case underscores the importance of histopathological examination for diagnosing rare leprosy complications.